Automated Cell Counter Market Size By Product Type (Fluorescence Image-based Cell Counter, Flow Cytometers, Coulter Counter), By Application (Blood Cells, Microbial Cells, Cell Lines), By End-use (Hospitals, Diagnostic Laboratories, Research Institutes, P

Automated Cell Counter Market Size By Product Type (Fluorescence Image-based Cell Counter, Flow Cytometers, Coulter Counter), By Application (Blood Cells, Microbial Cells, Cell Lines), By End-use (Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical & Biotechnology Companies), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030

The global automated cell counter market is poised to gain significant momentum and record an appreciable valuation by 2030, owing to the surging incidences of infectious and chronic ailments, such as cancer, CVDs, kidney diseases, etc. globally.

Based on recent facts and figures by the American Cancer Society, approximately 1.9 million new cancer cases were diagnosed in the United States in 2021, with the disease accounting for an estimated 608,570 deaths in the country. The rapid growth in the global disease burden has resulted in the improving health awareness about timely disease diagnosis and treatment among people, fostering the demand for diagnostic tests and preventive therapies. These, in tandem, will transform the automated cell counter market dynamics over the forthcoming years.

The automated cell counter industry is categorized on the basis of product type, application, end-use, and region.

With regard to product type, the flow cytometer segment is anticipated to depict decent growth trends and account for a sizeable valuation by 2030. The expansive range of research applications of flow cytometry, such as immunophenotyping, cell cycle analysis, cell sorting, apoptosis, cell proliferation assays, and intracellular calcium flux, may bolster the product demand in the coming years. Besides, the utilization of the technique in diagnosis and potential treatment of bone marrow and blood cancers may propel the flow cytometer sales during the projection period.

In terms of application, the others segment held over 6% market share in 2021 and is likely to drive lucrative growth between 2022 and 2030. The booming geriatric population base who are more prone to several chronic health conditions and infectious diseases may propel the demand for automated cell counter systems. Additionally, the increasing health concerns and the subsequent rise in healthcare expenditure may augment the market growth during the analysis timeframe.

Regarding the end-use, the research institutes segment was worth more than USD 650 million in 2021 and is projected to hold a considerable revenue share by 2030. The segmental growth is credited to the growing pervasiveness of several health disorders and the increasing demand for advanced diagnostic equipment across healthcare settings. The accelerating R&D efforts by the premier research establishments to leverage advanced technologies and introduce novel products may drive appreciable gains to the automated cell counter industry in the coming years.

Regionally, the North America automated cell counter market accounted for over 35% revenue share in 2021 and is likely to depict appreciable growth between 2022 and 2030. The surging blood examination procedures led by the increasing number of surgical interventions will foster product adoption across North America. Besides, significant investments in the healthcare infrastructure, coupled with the favorable reimbursement policies will positively influence the regional landscape.